Q1 2025 Morepen Laboratories Ltd Earnings Call Transcript
Key Points
- Morepen Laboratories Ltd (BOM:500288) reported the highest ever EBITDA in the last 40 years.
- The company successfully completed a QIP, raising INR200 crores for capacity expansion.
- Institutional holding increased significantly from 3-4% to 10.61%, attracting major global investors.
- The company is debt-free and has shown substantial growth in EBITDA margins, up 93% year-over-year.
- Medical devices business grew by 20%, contributing to a 14% overall revenue increase.
- Profit after tax was slightly lower due to tax liabilities, missing the highest-ever mark by INR1-1.5 crores.
- The company faced technical issues during the earnings call, causing interruptions.
- There was a 33% drop in the US market for API exports in the first quarter.
- India market exposure for APIs was reduced by 16% due to lower yields.
- The company does not provide specific future guidance, which may leave investors uncertain about exact future performance.
Ladies and gentlemen, good day and welcome to Morepen Laboratories Q1 FY25 conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Tushar Manudhane from Motilal Oswal. Thank you, and over to you, sir.
Apologies for the delay in start of the call. Good morning, and I welcome you all for the first quarter FY25 Fundings Call of Morepen Labs hosted by Motilal Oswal Financial Services. From the management side, we have Mr. Sushil Suri, Chairman and Managing Director; Mr. Ajay Kumar Sharma, Chief Financial Officer; Mr. Nishant Doshi, Vice President, Corporate Finance and Investor Relations; and Vipul Kumar Srivastava, Company Secretary and Compliance Officer.
Over to you, sir, for the opening remarks.
Good morning. Good morning, everybody. And again, sorry for this delay because
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
